Picture of Xintela AB logo

XINT Xintela AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual cashflow statement for Xintela AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2020
December 31st
R2021
December 31st
R2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSInterim ReportInterim ReportARSPRESS
Standards:
SAS
SAS
SAS
SAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-33.9-59.6-69.1-57.2-39.4
Depreciation
Non-Cash Items00-3.055.821.89
Other Non-Cash Items
Changes in Working Capital91.21-5.23-5.46-3.69
Change in Accounts Receivable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-21.3-54.9-73.1-53.1-40.7
Capital Expenditures-0.383-2.430-0.1040
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.0540.0530.22400
Sale of Fixed Assets
Sale/Maturity of Investment
Other Investing Cash Flow
Cash from Investing Activities-0.329-2.380.224-0.1040
Financing Cash Flow Items-13.7
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities54.834.770.451.850.1
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash33.2-22.6-2.8-0.5348.87